Clinical Trials Logo

Covid19 clinical trials

View clinical trials related to Covid19.

Filter by:

NCT ID: NCT04724720 Active, not recruiting - Covid-19 Clinical Trials

Famotidine vs Placebo for the Treatment of Non-Hospitalized Adults With COVID-19

Start date: January 19, 2021
Phase: Phase 2
Study type: Interventional

The overall objective of this study is to evaluate the clinical efficacy of oral famotidine in symptomatic non-hospitalized patients with confirmed COVID-19. This study is expected to enroll up to 84 patients with mild to moderate symptoms divided into each of the two study arms. Clinical outcomes of the two treatment arms will be compared. This study will be conducted virtually/remotely.

NCT ID: NCT04724434 Active, not recruiting - Clinical trials for SARS-CoV-2 Positive Patients

Follow-up Study of COVID-19 Patients in the District Konstanz

FSC19-KN
Start date: December 4, 2020
Phase:
Study type: Observational

This is a prospective single-center study for the follow-up of SARS-CoV-2 positive patients in the district of Konstanz (LKN). As part of the coronavirus pandemic, patients with SARS-CoV-2 infection are currently being treated in the clinics of the LKN's health network at the Singen (Hegau-Bodensee Clinic) and Konstanz (Konstanz Clinic) locations. So far, there is little data on the long-term effects of SARS-CoV-2 infection. As part of this study, the disease progression of these patients will be monitored. Study objective: Prospective, controlled follow-up observation of SARS-CoV-2 positive patients regarding their secondary diseases and quality of life.

NCT ID: NCT04721236 Active, not recruiting - Covid19 Clinical Trials

Early Use of Hyperimmune Plasma in COVID-19

COV-II-PLA
Start date: November 19, 2020
Phase: N/A
Study type: Interventional

The study assesses the efficacy of early administration of hyperimmune plasma in covid-19 patients who are on CPAP or intubated. Efficacy is measured as a 2 point decrease in the WHO scale

NCT ID: NCT04720612 Active, not recruiting - Covid19 Clinical Trials

COVID-19 Immunologic Antiviral Therapy With Omalizumab

CIAO
Start date: October 15, 2021
Phase: Phase 2
Study type: Interventional

To evaluate if omalizumab is effective in decreasing mortality in severe hospitalized COVID-19 cases.

NCT ID: NCT04719208 Active, not recruiting - Covid19 Clinical Trials

[COVID-19] Reduction of Sars-CoV-2 Oral Viral Load With Prophylactic Mouth Rinse

Start date: October 6, 2020
Phase: N/A
Study type: Interventional

The purpose of this study is to test the effectiveness of prophylactic mouth rinses in reducing the amount of viruses, specifically SARS-CoV-2 in the oral cavity. This research will guide dental and medical providers on best practices to be performed prior to dental and medical procedures involving the oral cavity.

NCT ID: NCT04718220 Active, not recruiting - Covid19 Clinical Trials

Safety, Testing/Transmission, and Outcomes in Pregnancies With COVID-19

STOPCOVID19
Start date: March 1, 2021
Phase: N/A
Study type: Interventional

Pregnant women are a vulnerable and high-risk population, as COVID-19 is associated with an increased risk preterm birth, cesarean section, and maternal critical care. This study will examine the factors that impede testing for SARS-CoV-2 (the causative virus among pregnant women), help determine optimal testing strategies by evaluating the necessity of testing for asymptomatic disease in pregnancy, inform prenatal care plans by assessing the full impact of infection, and contribute to a provider's ability to counsel women and create prenatal care plans if they are pregnant or considering pregnancy.

NCT ID: NCT04716985 Active, not recruiting - Covid19 Clinical Trials

Evaluation of the Daily Intake of 0.5 L of Water Saturated With Molecular Hydrogen for 21 Days in COVID-19 Patients Treated in Ambulatory Care

HYDRO COVID
Start date: January 22, 2021
Phase: N/A
Study type: Interventional

Through its anti-inflammatory role, molecular hydrogen could have a beneficial effect in preventing the runaway inflammatory reactions that lead to complications of Covid-19. This hypothesis is supported by numerous preclinical and theoretical arguments, as well as by some Chinese clinical studies (the Chinese guidelines for the management of Covid-19 recommend the inhalation of hydrogen), a recommendation whose interest has just been confirmed by a publication describing the very positive results of a clinical study in China. Through its anti-inflammatory role, molecular hydrogen could have a beneficial effect in preventing the runaway inflammatory reactions that lead to complications of Covid-19. The ingestion of water saturated with molecular hydrogen has been the subject of several clinical studies in other indications than Covid-19, and no side effects of this ingestion have been reported. A recent publication recommends initiating clinical trials using a hydrogen fortified beverage.

NCT ID: NCT04715854 Active, not recruiting - Covid19 Clinical Trials

Effect on paO2 of Adding an Aerosol Mask Above the Nasal Canulas

Start date: February 19, 2021
Phase: N/A
Study type: Interventional

This study will compare the impact of a classical aerosol mask above low-flow nasal cannula on the arterial oxygen tension in patients with COVID-19.

NCT ID: NCT04713488 Active, not recruiting - COVID-19 Prevention Clinical Trials

An Open Study on the Safety, Tolerability, and Immunogenicity of "Sputnik Light" Vaccine

Start date: January 15, 2021
Phase: Phase 1/Phase 2
Study type: Interventional

Phase I-II open prospective, two-stage, non-randomized study in healthy volunteers.

NCT ID: NCT04713150 Active, not recruiting - Covid19 Clinical Trials

HEALthy Brain and Child Development Study - COVID-19 Supplement

Start date: October 5, 2020
Phase:
Study type: Observational

The purpose of this study is to advance the scientific understanding of how a prenatal COVID-19 infection and associated psychological distress influences infant neurodevelopment. This project will aim to shed light on how families and child development are impacted by the current COVID-19 pandemic and will work to better support these families and children as they grow.